Last reviewed · How we verify
Kenalog
At a glance
| Generic name | Kenalog |
|---|---|
| Also known as | Drug: Kenalog, Other Names:, triamcinolone acetonide injectable suspension, Triamcinolone Acetonide, kenalog in orabase |
| Sponsor | Cale Jacobs |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Boxed warnings
- WARNING: RISK OF CARDIAC ARREST WITH USE OF BUPIVACAINE HYDROCHLORIDE INJECTION IN OBSTETRICAL ANESTHESIA There have been reports of cardiac arrest with difficult resuscitation or death during use of Bupivacaine Hydrochloride Injection for epidural anesthesia in obstetrical patients. In most cases, this has followed use of the 0.75% (7.5 mg/mL) concentration. Resuscitation has been difficult or impossible despite apparently adequate preparation and appropriate management. Cardiac arrest has occu
Common side effects
- Hypotension
- Positional headaches
- Backache
- Shivering
- Nausea
- Double vision
- Respiratory inadequacy
- Peripheral nerve symptoms
- Dizziness
- Drowsiness
- Nervousness
- Apprehension
Serious adverse events
- Convulsions
- Respiratory depression and arrest
- Unconsciousness
- Cardiovascular collapse
- Cardiac arrest
- Bradycardia
- Anaphylactic reactions
- Total spinal block
- Permanent injury to extraocular muscles
- Methemoglobinemia
Key clinical trials
- Dose Dependent Steroid Injections (PHASE4)
- A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome (PHASE4)
- Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia (NA)
- Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone (PHASE4)
- USG-Guided Shoulder Injections in Frozen Shoulder (NA)
- Local Methotrexate Injections for the Treatment of Nail Psoriasis (PHASE4)
- Bladder Directed vs. Pelvic Floor Therapy in IC/BPS (PHASE2)
- Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kenalog CI brief — competitive landscape report
- Kenalog updates RSS · CI watch RSS
- Cale Jacobs portfolio CI